Zepbound’s price depends on one thing first: whether a plan covers it. If yours does, Lilly’s savings card can bring a fill to as little as $25 [3]. If it doesn’t, LillyDirect sells it for $299 to $449 a month by dose [2]. Medicare has its own route, and the list price sits far above all three. Here’s each price with the conditions that come attached.
Zepbound’s price at a glance
| Route | Who it’s for | Price per fill | Conditions | Source |
|---|---|---|---|---|
| Savings card, plan covers Zepbound | Commercial insurance | As little as $25 | Card saves up to $100 a month and $1,300 a year; up to 13 fills; ends December 31, 2026 | Lilly [3] |
| Savings card, plan doesn’t cover it | Commercial insurance | As low as $499 (single-dose pen) | 1-month fill | Lilly [3] |
| LillyDirect self-pay, 2.5 mg | Eligible self-pay patients with a valid prescription | $299 | Starting dose only | LillyDirect [2] |
| LillyDirect self-pay, 5 mg | Eligible self-pay patients with a valid prescription | $399 | Needles extra | LillyDirect [2] |
| LillyDirect self-pay, 7.5 to 15 mg | Eligible self-pay patients with a valid prescription | $449 | Refill within 45 days; otherwise $499 (7.5 mg) or $699 (10 to 15 mg) | LillyDirect [2] |
| Medicare GLP-1 Bridge | Eligible Part D enrollees | $50 copay | July 1, 2026 to December 31, 2027; CMS sets eligibility | CMS [4] |
| TrumpRx | Self-pay | $299 lowest deal | TrumpRx shows $1,087 as the “Original Price” | TrumpRx [5] |
Lilly’s savings terms define a month as 28 days [3]. Manufacturer and government prices as currently listed.
Without insurance, LillyDirect charges $299 to $449 a month
Through LillyDirect, Zepbound vials and KwikPens cost $299 a month at the 2.5 mg starting dose and $399 at 5 mg [2]. Every higher dose, from 7.5 mg to 15 mg, costs $449 a month, but only “when you refill within 45 days.”
Outside the purchase window, Lilly lists regular prices of $499 for 7.5 mg and $699 for 10, 12.5 or 15 mg [2]. On a 15 mg dose, one late refill costs $250 more than an on-time one.
| Dose | Refill within 45 days | Regular price | Notes |
|---|---|---|---|
| 2.5 mg | $299 | $299 | Starting dose; not approved as a maintenance dose |
| 5 mg | $399 | $399 | Needles bought separately |
| 7.5 mg | $449 | $499 | Needles bought separately |
| 10 mg | $449 | $699 | Needles bought separately |
| 12.5 mg | $449 | $699 | Needles bought separately |
| 15 mg | $449 | $699 | Needles bought separately |
Vials need a needle and syringe; KwikPens need pen needles [2].
Two details affect comparison. The $299 strength is for initiation, not approved maintenance. Vials require needles and syringes; KwikPens require pen needles purchased separately. Taxes, fees and offer eligibility may also affect the final bill. The manufacturer can change or withdraw the offers [2].
Separate 365-day cash payments from annualized cost
A 28-day supply is not a calendar month. If a hypothetical patient buys a supply on day zero and every 28 days thereafter, payments fall on days 0, 28 and so on through day 364: fourteen purchases within the first 365 days. The last supply extends beyond that period. This cash-payment count differs from annualizing consumption as 365 divided by 28 [2].
| Price per 28-day supply | 14 purchases in first 365 days | Annualized cost: price × 365 ÷ 28 |
|---|---|---|
| $399 | $5,586 | $5,201.25 |
| $449 | $6,286 | $5,853.04 |
| $499 | $6,986 | $6,504.82 |
| $699 | $9,786 | $9,112.32 |
Our arithmetic from currently listed package prices, not a treatment plan or guaranteed annual quote. Dose changes, card fill caps, offer expiration, taxes and supplies can change actual payments [2] [3].
Do not budget a full year at the initiation price or assume a savings card covers every purchase in that year. Ask the pharmacy what happens after the applicable fill cap or offer expiration. The cost calculator separates renewal timing from a monthly comparison, while the billing checklist helps identify additional program commitments.
With coverage, the savings card can cut a fill to $25
For eligible commercially insured patients with coverage of the single-dose pen, the card advertises payments as low as $25 for qualifying one-, two- or three-month fills. Maximum savings are $100, $200 or $300 respectively, with a separate $1,300 calendar-year cap and up to thirteen fills. The listed savings end December 31, 2026. An approved-use prescription, activation and other eligibility conditions apply [3].
These are limits, not a guaranteed $25 bill. If a qualifying patient's share is $150 and the card provides its maximum $100 benefit, $50 remains. Government-program beneficiaries are excluded from this card. Alternative-funding arrangements can also make a patient ineligible. Card savings cannot be combined with another Zepbound discount or claimed for reimbursement [3].
The noncovered commercial-insurance offers differ by device. The single-dose pen is advertised as low as $499, with up to thirteen fills. The KwikPen offer has strength-specific prices and a maximum of eleven fills per calendar year. Its higher-strength purchase offer initially applies automatically, then requires refill purchase within 45 days after receipt of the prior supply. Additional taxes and fees can apply. Do not assume the terms for a pen, KwikPen and vial are identical [3].
Before filling, ask the pharmacy to confirm the exact device, eligibility, remaining card benefit and final amount due. Activation does not guarantee that every pharmacy can process every offer. Refill timing for a discount is a commercial condition, not a reason to alter the prescribed schedule. Lilly reserves the right to change or end the program [3].
Your plan’s formulary decides coverage, not your insurer’s name
Commercial-plan coverage varies. The answer sits in your specific plan’s formulary, the list of drugs it pays for. A general statement about an insurer cannot establish a particular employer or individual plan’s terms. Lilly advertises availability on selected CVS Caremark formularies while explicitly stating that coverage is not guaranteed [3].
- Find your plan’s drug list (formulary) in your member portal, or call the number on your card.
- Look up Zepbound’s tier, and whether it needs prior authorization (approval before the plan pays).
- Ask whether your plan excludes drugs used for weight loss. Some plans do.
- Ask whether your plan treats sleep apnea differently. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity [7], and some plans handle that use separately.
Medicare: the GLP-1 Bridge charges a $50 copay
Medicare generally excludes drugs used for weight management from the ordinary Part D benefit. A separately covered indication can change the analysis: Zepbound has an adult obstructive-sleep-apnea indication for patients with obesity. Ask the plan to evaluate the actual prescribed use rather than assuming all Zepbound prescriptions are either covered or excluded [6] [7].
The Medicare GLP-1 Bridge is a separate demonstration running from July 1, 2026 through December 31, 2027. Eligible beneficiaries pay $50 for a qualifying 28- or 30-day supply outside the Part D payment flow. The Part D deductible does not apply, these payments do not count toward its out-of-pocket limit, and the Bridge provides no low-income subsidy. The Medicare Prescription Payment Plan cannot spread these Bridge payments [4] [6].
Lilly says eligible Part D patients prescribed Zepbound for weight management can get it through the Bridge at the advertised eligible copay [3]. Clinical eligibility and prior authorization are required; and CMS runs prior authorization through a central processor [4]. Check whether you qualify through Medicare before you count on the $50 price.
TrumpRx lists Zepbound at $299, the same as LillyDirect
TrumpRx lists Zepbound at $299 a month as its lowest deal, against an “Original Price” of $1,087 (TrumpRx) [5]. The $299 matches LillyDirect’s starting-dose price. TrumpRx’s homepage doesn’t show its higher-dose prices, so check the dose you’ll be on before you compare.
A list-price reference is not a personal quote
TrumpRx's higher reference figure is not proof of what a particular patient will pay. Today's offers also cannot establish next year's price. Lilly's savings terms have an expiration date and allow changes before then. Ask the dispensing pharmacy for the exact package, final cost and offer restrictions rather than relying on a headline from an older article [5] [3].
Separate the prescribing service from the medication quote
A telehealth service may charge for visits, membership, laboratory work or insurance paperwork separately from medication. Request each component in writing. The Found review illustrates why insurance-based care, a cash membership and a medication plan need separate treatment. The insurance guide explains the questions to ask before treating an estimated copay as a complete program cost.
Confirm where the prescription will be sent, whether the selected device is eligible for the quoted offer, who handles prior authorization, and what remains payable if treatment is declined or coverage denied. Ask whether ending medication also cancels a service membership. A medication discount does not automatically refund a separately contracted visit or prepaid plan.
Compare the eligible total for your prescribed treatment
The $299 headline is an initiation-strength offer, not a universal price floor or long-term quote. The 5 mg offer is $399; higher-strength offers and their restrictions differ. Commercial insurance, ordinary Part D coverage for another indication and Bridge eligibility require separate checks. The lowest advertised number is useful only when the patient, device and fill meet its conditions [2] [3].
Compounded tirzepatide costs $85–$399 a month across programs on this site, but it isn’t Zepbound. Compounded preparations do not receive FDA premarket review for safety, effectiveness or quality. This does not mean pharmacies operate without oversight [1]. Prices are in compounded tirzepatide cost, the trade-offs are in compounded tirzepatide vs Zepbound, and sources are in where to get compounded tirzepatide. Programs are scored on the compounded tirzepatide scores.
The reviewed self-pay and savings pages do not establish a free-medicine route; they are not an exhaustive inventory of assistance programs. If cost rules out every route here, ask your prescriber or Lilly whether you might qualify for patient assistance. For other brands, see Wegovy cost and Ozempic cost without insurance. Doses are explained in Zepbound dosage, and the drug itself on the Zepbound page.